ClinConnect ClinConnect Logo
Search / Trial NCT04746417

Assessment of Skeletal Maturity Using Proximal Femoral Epiphysis in Patients With Scoliosis

Launched by THE UNIVERSITY OF HONG KONG · Feb 5, 2021

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how to assess bone growth in patients with idiopathic scoliosis, a condition where the spine curves abnormally. Researchers want to see if examining a specific part of the hip bone, called the proximal femoral head, can help determine when a child or teenager has finished growing. This information is important because it can help doctors make better decisions about treatment for scoliosis. The study will create a grading system to measure skeletal maturity and will check if this system is reliable for use in a medical setting.

To participate in the trial, you need to be diagnosed with idiopathic scoliosis and have certain growth plates in your bones that are still open. Unfortunately, if you have scoliosis due to another cause, or if you have a growth hormone deficiency or developmental delays, you wouldn't qualify to join. The trial is currently looking for participants aged between 2 and 65 years, and both boys and girls can take part. If you join, you can expect to have your bone growth assessed through imaging and other evaluations, contributing to important research that may improve care for patients with scoliosis in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Idiopathic scoliosis
  • Open triradiate cartilage or open distal radius epiphysis without capping
  • Exclusion Criteria:
  • Non-idiopathic scoliosis
  • Patients with growth hormone deficiency or developmental delay
  • Patient has not reached skeletal maturity
  • Defaulted and lost to follow-up

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials